key: cord-0898809-4gwj2ior authors: Hoyo, Javier Del; Millán, Mónica; Garrido-Marín, Alejandro; Nos, Pilar; Acosta, Manuel Barreiro-de; Bujanda, Luis; de la Portilla, Fernando; Aguas, Mariam title: Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path towards the implementation of telemedicine in Spain? date: 2021-09-08 journal: Gastroenterol Hepatol DOI: 10.1016/j.gastrohep.2021.08.006 sha: e2dc77c79869fe9ed3ae17f1f763040f103e2048 doc_id: 898809 cord_uid: 4gwj2ior Background: COVID-19 pandemic increased medical services demand aside from interrupting daily clinical practice for other diseases such as Inflammatory Bowel Disease (IBD). Here we present the results of a survey to gain the perception of IBD specialists in their patient-management using telemedicine in their daily practice. Methods: This was an observational survey study among physicians focused on IBD (gastroenterologist, surgeons, and pediatricians) members of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU), the Spanish Association of Gastroenterology (AEG), and the Spanish Association of Coloproctology (AECP), regarding changes of management of IBD patients. Results: We received a total of 269 responses to the survey (from May to June 2020). Before the pandemic, nearly all the respondents reported performing very frequently their visits face-to-face (n=251, 93.3%) while, during the pandemic, the telephone visits were the most frequent visits performed (n=138, 51,3%). Regarding communication difficulties, 157 (58.4%) respondents reported the impossibility of performing a proper examination as the most relevant issue. Also, 114 (42.4%) respondents considered remote visits more time-consuming than face-to-face visits. Most gastroenterologists (n=188, 83.2%) considered patients with active perianal disease in special need of face-to-face consultation and more than half of the surgeons (n=35, 50.7%) reported having performed an immediate postoperative follow-up remotely. Conclusions: Most IBD units have implemented remote visits during the pandemic, but most professionals found them more time-consuming and unsuitable for some disease profiles. Therefore, there is a need for the development of better telemedicine systems that can meet professionals’ and patients´ requirements. Introducción: La pandemia por COVID-19 ha supuesto un incremento en la demanda de atención 71 sanitaria y ha modificado el modelo asistencial de algunas patologías como la Enfermedad Inflamatoria 72 Intestinal (EII). Presentamos los resultados de una encuesta sobre el papel de la telemedicina en el 73 manejo de pacientes con EII. 74 Material y métodos: Estudio observacional mediante encuesta dirigida a gastroenterólogos, cirujanos 75 y pediatras especializados en EII, miembros del Grupo Español de Trabajo en Enfermedad de Crohn y 76 Colitis Ulcerosa (GETECCU), la Asociación Española de Gastroenterología (AEG) y/o la Asociación 77 Española de Coloproctología (AECP). 78 Resultados: Recibimos un total de 269 respuestas (mayo a junio de 2020). Antes de la pandemia, el 79 93,3% de los participantes afirmó llevar a cabo la mayor parte de sus consultas de manera presencial. 80 Durante la pandemia, la consulta telefónica se ha convertido en la modalidad preferida por el 51,3%. 81 El principal inconveniente de la asistencia telemática fue la imposibilidad de llevar a cabo una 82 exploración física según el 58,4%. Además, el 42,4% aseguró emplear más tiempo en este tipo de 83 consultas. Entre gastroenterólogos, el 83,2% consideró que el paciente que más puede beneficiarse de 84 la visita presencial es aquel con enfermedad perianal activa. Y, por último, el 50,7% de los cirujanos 85 afirmó haber realizado controles remotos en el postoperatorio inmediato. individuals with immune-inflammatory diseases is still unknown (2), and the appropriate and follow-107 up of IBD patients have become a challenge. 108 One of the main concerns of patients with IBD during the pandemic has been the interruption of face-109 to-face medical visits, due to mobility restrictions and lockdowns imposed in most countries during the 110 months of maximum spread of the virus. Moreover, the decrease in endoscopic explorations and 111 scheduled surgeries, the interruption of some clinical trials, as well as usual daily practice, have 112 generated considerable concern among both patients and health professionals (4, 5). In Spain, because 113 of the pandemic restrictions, many health centers activated telephone and email helplines to answer 114 patients' queries on the risk of infection by their prescribed treatment, or IBD itself. 115 For all these reasons, remote consultation has become an essential tool to minimize face-to-face visits 116 in the hospitals, while ensuring adequate monitoring and control of the disease in these patients. In 117 other countries, some preexisting remote monitoring platforms, such as TELE-IBD, myIBDcoach, and 118 HealthPROMISE, have proven to be safe and effective in ensuring the appropriate follow-up of IBD 119 patients (6-9). 120 In Spain, our study group developed the web platform TECCU, which proved to be a safe, cost-effective 121 strategy to improve health outcomes, especially in complex IBD patients (10, 11). Besides providing 122 remote healthcare, telemedicine is extremely useful during a pandemic for minimizing exposure to the 123 virus. Moreover, telemedicine enhances education and telemonitoring that can promote patients' 124 empowerment and self-management (12, 13) and could also alleviate the pressure on healthcare 125 system in routine practice. However, its forced implementation as a response to the current situation 126 may raise some concerns about its use in some settings. Therefore, the main aim of this study was to 127 gather information on the changes and challenges perceived by IBD specialists, including general 128 gastroenterologists, pediatricians, and surgeons in the management of IBD patients using remote 129 systems in their daily practice, to understand the advantages and disadvantages of telemedicine during 130 the COVID-19 pandemic. J o u r n a l P r e -p r o o f This was an observational survey study conducted to assess changes in the management of IBD 134 patients due to the COVID-19 pandemic and the satisfaction of health professionals with the available 135 remote visit systems. 136 We designed an 18-question survey using the SurveyMonkey platform. Questions included 137 demographic characteristics and questions related to medical practice before and after the onset of 138 the pandemic. Five specific questions addressing specialists on their practice were also included. 139 Answers were collected anonymously, and all the information was processed following Organic Law were made later before the deadline for submission (June 28 th , 2020). 146 A descriptive analysis of the survey responses was made, with continuous variables reported as 148 medians and interquartile range, and categorical variables reported as percentages (%) with 95% 149 confidence intervals. 150 Surveys were sent to the mailing lists of the members of the Spanish scientific societies AEG, GETECCU, 154 and AECP (n = 1383, n = 940, and n = 582, respectively). However, some of the professionals are 155 members of more than one society, so the total number of surveys received by professionals, taking 156 into account possible redundancies, was 1286. The total number of valid responses received between 157 May 25 th and June 28 th of 2020 was 269 (Figure 1) . 158 Catalonia and the Valencian Community were the regions with most respondents, followed by Madrid 159 Community and Andalusia (Figure 2 ). Most respondents were gastroenterologists, followed by 160 surgeons and pediatricians (80.7%, 217/269; 16.4%, 44/269; and 3.0%, 8/269; respectively), and 161 younger than 40 or between 40 and 50 years old (39.4%, 106/269 and 34.6%, 93/269, respectively). 162 Three out of four health professionals worked in a public university hospital and very few worked in 163 private centers (75.1%, 202/269 and 2.2%, 6/269, respectively). Almost all respondents used electronic 164 medical records in their daily practice (97.8%, 263/269). 165 Regarding the routine practice of respondents before the onset of the pandemic, nearly all reported 167 conducting most of their patient visits face-to-face (75-100%) (Table 1, Figure 3 ). Most respondents 168 reported offering medical care by telephone occasionally (0-25% of visits). More than half of the 169 respondents acknowledged occasionally following up patients via email (0-25% of visits), or while one 170 fifth did this slightly more frequently (25-50%). Notably, more than half of the respondents reported 171 that contacting patients by video calls was not an option in their routine practice (Table 1, Figure 3) . 172 Since the onset of the pandemic, all respondents reported using telephone medical care for some of 174 their patients (Table 1, Figure 3) . Half of the respondents conducted visits by telephone in almost all 175 cases (75-100% of the visits), and a further third conducted half or more of their visits by telephone. 176 Remarkably, since the onset of the pandemic, the number of respondents using email to assist their 177 patients increased. Before the pandemic, only 1 participant out of 269 reported using email frequently 178 (i.e., more than 50% of the visits), whereas after the onset of the pandemic, this proportion increased 179 to 32 out of 269 respondents (Table 1, Figure 3 ). (61.7%, 166/269) and nearly one out of three respondents (34.2%, 92/269) reported using video call 182 consultation very occasionally (0-25% of the visits) (Table 1, Figure 3) . 183 Nearly half of the respondents (46.1%, 124/269) reported that they did not have an email account for 185 medical consultations. Of the respondents who did have an email account for medical consultations 186 with their patients (53.9%, 145/269), more than half (27.9%, 75/269) reported that they controlled the 187 account themselves while nearly one-third (17.5%, 47/269) reported that the specialist nurse 188 maintained control of the email account. 189 Just over half of the respondents (51.7%, 139/269) reported using email for medical consultations with 190 patients. Of these, more than half (64%, 89/139) were consultations related to the disease, while the 191 remaining consultations (36%, 50/139) were related to administrative aspects (change of 192 appointments, medical reports, prescriptions, etc.) . 193 More than half of the respondents reported some disadvantages associated with remote visits 195 compared to face-to-face visits ( Table 1) . The inconvenience reported most frequently as very relevant 196 was the impossibility of examining patients. Respondents also considered it very relevant that some 197 consultations are not completed properly (e.g., missing visits or tests). Furthermore, 38 out of 269 198 respondents indicated that the physician-patient emotional relationship is more difficult in remote 199 visits, and 18 out of 269 respondents noted that the patients' difficulties in communicating their 200 current health status prevents a correct assessment ( Table 1) . 201 Most respondents reported that remote visits take longer than face-to-face visits or at least the same 202 amount of time. Less than a third of respondents reported spending less time in remote visits than in 203 face-to-face visits ( Table 1) . 204 205 Some of the last questions of the questionnaire specifically addressed gastroenterologists and others 207 to surgeons. 208 Most gastroenterologists believe that face-to-face visits are essential for patients with active perianal 209 disease and cases of clinical exacerbation ( Table 2) . and most of them considered the main difficulty was revision of the surgical wound (Table 3) . 212 The COVID-19 pandemic has created a huge challenge for the safe provision of quality care. Spain is 215 one of the most affected countries and this has dramatically altered care pathways in healthcare 216 centers and, with it, our routine management of outpatients with IBD (4, 5, 14-16). The results of our 217 study showed that many IBD units have adapted to the circumstances using telephone and e-mail to 218 contact their patients, and these tools have expanded their presence in clinical practice during the 219 pandemic. They are usually considered useful and cost-effective, but the perspective of healthcare 220 professionals with their use has not been addressed thus far. 221 Although patients with IBD are at increased risk of infection due to immunosuppression, the incidence 222 of SARS-CoV-2 infection in IBD patients is estimated to be similar to that of the general population (3, 223 17). Data are still scarce and minimizing exposure in these patients is a priority. To this end, a key tool 224 during the pandemic has been the use of telemedicine, understood as the provision of medical care 225 using communication technologies in the form of text, video, or audio (17). This strategy not only 226 reduces the individual risk of exposure to the virus but also reduces community transmission in high-227 traffic areas such as hospitals and health centers, care burdens at times of high demand, and the use 228 of personal protective equipment. It is also safe, easy to use, and well accepted by most patients (6, 8, 229 18) . 230 Despite the exceptional nature of the situation in which we find ourselves and the potential benefits 231 of telemedicine, its increasing use raises new doubts and uncertainties that are hampering its 232 widespread implementation. Among them, confusion regarding medical liability due to the absence of 233 specific regulations governing its use in our legal system of laws and regulations. Moreover, 234 telemedicine has been successful in some patients and in certain disease profiles, but not in others, 235 and some patients have an inherent need for face-to-face physical explorations, such as those with 236 active perianal disease, as pointed out by the gastroenterologists who participated in this survey. Thus, 237 the favorable efficacy and cost-effectiveness reported in previous trials (11) may not apply to all 238 patients and, besides, more than 70% of respondents in our survey reported that telephone 239 consultations were not time-saving procedures. In addition to the disadvantages of remote visits most 240 frequently reported by the study respondents, namely the impossibility to perform examinations and consider is access to telemedicine, especially for older patients, whether due to the lack of a device or 243 the difficulties that patients may encounter in its use. Another important barrier may be the 244 integration of IBD telemedicine platforms in electronic medical records, although some efforts have 245 been made towards solving this specific issue (19) . Regardless of the current or future possible 246 pandemic events, telemedicine shows the potential, in terms of cost-effectivity and suitability to be 247 the future standard to manage IBD patients(11, 15). Thus, efforts must be focused on the further 248 promotion and the application of telemedicine platforms properly integrated into all levels of the 249 health care system. 19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial 289 phase of the pandemic (February-April 2020). Gastroenterologia y hepatologia. 2020;43 (7) Centre for Disease Prevention and Control -COVID-19 pandemic 2020 279 Review of inflammatory bowel disease 281 and COVID-19 The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients Crohn's & colitis 360 Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: 286 Results From a National Survey Telemedicine for COVID-19 Telemedicine in Inflammatory Bowel Disease: 316 Opportunity Ahead. Inflammatory bowel diseases International Organization for the Study of 318 Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases. 319 Journal of Crohn's & colitis Relevant Infections 321 in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their 322 Effects on Disease Mortality HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory 325 Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial Development and 328 feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of 329 concept study for patients with inflammatory bowel disease in remission on biological therapy. 330 Scandinavian journal of gastroenterology Frequently (50-75%) Very frequently Not Available How did you manage your patients DURING the COVID-19 pandemic? Frequently (50-75%) Very frequently In the telematic assistance of your Service, which health professional is in charge of controlling the email? Specialist nurse Very high Among your IBD patients, which have a special need of a face-to-face consultation?* Patients with active perianal disease 1. What was the average proportion of these diseases among your patients before the onset of the pandemic? Very high Inflammatory bowel disease None Low Very high Very high Pelvic floor or functional disease None Low Very high Have you performed "immediate" postoperative follow-ups remotely? (first visits after surgery or similar) Yes No